Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
7.96 USD | -3.52% | -13.85% | -20.87% |
Kurzporträt
Mitarbeiterzahl: 587
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Antibody-based Therapies
100,0
%
| 1 616 | 100,0 % | 86 | 100,0 % | -94.67% |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 1 616 | 100,0 % | 86 | 100,0 % | -94.67% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Chief Executive Officer | 56 | - | |
Sung Lee
DFI | Director of Finance/CFO | 53 | 27.03.23 |
Jennifer Towne
CTO | Chief Tech/Sci/R&D Officer | - | 06.11. |
Aine M. Hanly
CTO | Chief Tech/Sci/R&D Officer | 54 | 01.03.21 |
George Scangos
BRD | Director/Board Member | 76 | 01.01.17 |
Richard Lepke
IRC | Investor Relations Contact | - | 01.01. |
Sasha Ellis
PRN | Corporate Officer/Principal | - | 10.07.23 |
Lynne Krummen
PRN | Corporate Officer/Principal | - | 01.01.18 |
Corporate Officer/Principal | 73 | - | |
Jeff Calcagno
PRN | Corporate Officer/Principal | - | 15.05.23 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Charles Sigal
BRD | Director/Board Member | 72 | 02.07.20 |
Robert Perez
BRD | Director/Board Member | 59 | 01.01.17 |
Robert More
BRD | Director/Board Member | 56 | 01.09.16 |
Phillip Sharp
BRD | Director/Board Member | 79 | 01.01.17 |
Robert Nelsen
FOU | Founder | 60 | 07.04.16 |
Vicki Sato
CHM | Chairman | 75 | 01.12.16 |
George Scangos
BRD | Director/Board Member | 76 | 01.01.17 |
Director/Board Member | 48 | 01.09.19 | |
Janet Napolitano
BRD | Director/Board Member | 65 | 28.08.20 |
Chief Executive Officer | 56 | - |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 135 032 268 | 115 816 259 ( 85,77 %) | 0 | 85,77 % |
Unternehmenskontakt
Sektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-20.87% | 1.07 Mrd. | |
-1.82% | 41.35 Mrd. | |
+42.89% | 40.38 Mrd. | |
+2.56% | 39.05 Mrd. | |
-12.11% | 26.67 Mrd. | |
+3.09% | 24.07 Mrd. | |
-24.16% | 18.36 Mrd. | |
+22.12% | 11.6 Mrd. | |
-3.74% | 11.68 Mrd. | |
+7.75% | 11.15 Mrd. |
- Börse
- Aktien
- A2PS0P Aktie
- Unternehmen Vir Biotechnology, Inc.